Fresenius Kabi US supplier risk profile and import data Q1 2026 analysis
Fresenius Kabi US imported 169 shipments in Q1 2026 across 10 suppliers in 9 countries. Norway dominated the sourcing profile, accounting for 81% of all shipments, primarily from HP Halden Pharma with 137 shipments. Italy was the second-largest source at 9% of shipments, led by Gerresheimer Moulded Glass Italy with 11 shipments of glass containers (HS Chapter 70). The import profile spans pharmaceutical preparations and glass packaging materials.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
Fresenius Kabi US recorded zero sanctions watchlist hits and zero suppliers with documented forced-labor exposure under UFLPA frameworks in Q1 2026. The import base shows no flagged compliance red flags across the measured supply chain depth.
10 distinct tier-1 suppliers in Q1 2026
| HP HALDEN PHARMA | Norway | 137 |
| GERRESHEIMER MOULDED GLASS ITALY SR | Italy | 11 |
| FRESENIUS KABI | Sweden | 6 |
| ACS DOBFAR | Italy | 4 |
| CLINICO MEDICAL SP Z O O | Poland | 3 |
| JIANGSU HENGRUI PHARMACEUTICALS | China | 3 |
| INFOMED FLUIDS SRL | Romania | 2 |
| FRESENIUS KABI DEUTSCHLAND | Germany | 1 |
Share of Q1 2026 inbound shipments by source country
17 tier-2 + 42 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.